Literature DB >> 15520456

Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages.

Geneviève Escher1, Anh Hoang, Suzan Georges, Urbain Tchoua, Assam El-Osta, Zygmunt Krozowski, Dmitri Sviridov.   

Abstract

This study was aimed at developing a method for high-efficiency transient transfection of macrophages. Seven methods were evaluated for transient transfection of murine macrophage RAW 264.7 cells. The highest transfection efficiency was achieved with DEAE-dextran, although the proportion of cells expressing the reporter gene did not exceed 20%. It was subsequently found that the cytomegalovirus plasmid promoter in these cells becomes methylated. When cells were treated with the methylation inhibitor 5-azacytidine, methylation of the plasmid promoter was abolished and a dose-dependent stimulation of reporter gene expression was observed with expression achieved in more than 80% of cells. Treatment of cells with 5-azacytidine also caused increased efficiency of transfection of macrophages with plasmids driven by RSV, SV40, and EF-1alpha promoters and transient transfection of human HepG2 cells. Inhibition of methylation also increased the amount and activity of sterol 27-hydroxylase (CYP27A1) detected in RAW 264.7 cells transfected with a CYP27A1 expression plasmid. Treatment of cells with 5-azacytidine alone did not affect either cholesterol efflux from nontransfected cells or expression of ABCA1 and CYP27A1. However, transfection with CYP27A1 led to a 2- to 4-fold increase of cholesterol efflux. We conclude that treatment with 5-azacytidine can be used for high-efficiency transient transfection of macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15520456     DOI: 10.1194/jlr.D400014-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  19 in total

Review 1.  DNA methylation levels of CYP2R1 and CYP24A1 predict vitamin D response variation.

Authors:  Yu Zhou; Lan-Juan Zhao; Xiaojing Xu; An Ye; Dianne Travers-Gustafson; Boting Zhou; Hong-Wei Wang; Weidong Zhang; L Lee Hamm; Hong-Wen Deng; Robert R Recker; Joan M Lappe
Journal:  J Steroid Biochem Mol Biol       Date:  2013-10-12       Impact factor: 4.292

2.  Analysis of signal transduction pathways in macrophages using expression vectors with CMV promoters: a cautionary tale.

Authors:  Madhuri Ramanathan; György Haskó; Samuel Joseph Leibovich
Journal:  Inflammation       Date:  2005-04       Impact factor: 4.092

3.  Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.

Authors:  A Hoang; A J Murphy; M T Coughlan; M C Thomas; J M Forbes; R O'Brien; M E Cooper; J P F Chin-Dusting; D Sviridov
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

Review 4.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

5.  Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient mice.

Authors:  Lesca M Holdt; Joachim Thiery; Jan L Breslow; Daniel Teupser
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-20       Impact factor: 8.311

6.  Antiretroviral compounds and cholesterol efflux from macrophages.

Authors:  Nigora Mukhamedova; Honor Rose; Huanhuan L Cui; Angela Grant; Urbain Tchoua; Anthony Dart; Michael Bukrinsky; Dmitri Sviridov
Journal:  Atherosclerosis       Date:  2009-03-21       Impact factor: 5.162

7.  Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo.

Authors:  Nigora Mukhamedova; Genevieve Escher; Wilissa D'Souza; Urbain Tchoua; Angela Grant; Zigmund Krozowski; Michael Bukrinsky; Dmitri Sviridov
Journal:  J Lipid Res       Date:  2008-07-12       Impact factor: 5.922

8.  Reliable and inexpensive expression of large, tagged, exogenous proteins in murine bone marrow-derived macrophages using a second generation lentiviral system.

Authors:  Matthew R Miller; Scott D Blystone
Journal:  J Biol Methods       Date:  2015

9.  An inhibitor screen identifies histone-modifying enzymes as mediators of polymer-mediated transgene expression from plasmid DNA.

Authors:  Matthew D Christensen; Rajeshwar Nitiyanandan; Seyedehmelika Meraji; René Daer; Sudhakar Godeshala; Sheba Goklany; Karmella Haynes; Kaushal Rege
Journal:  J Control Release       Date:  2018-06-28       Impact factor: 9.776

10.  Regulated expression of CCL21 in the prostate tumor microenvironment inhibits tumor growth and metastasis in an orthotopic model of prostate cancer.

Authors:  Nazita Yousefieh; Suzanne M Hahto; Amber L Stephens; Richard P Ciavarra
Journal:  Cancer Microenviron       Date:  2009-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.